Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing “one-stop” hybrid coronary revascularization

References

• Reicher B, Poston RS, Mehra MR, Joshi A, Odonkor P, Kon Z, Reyes PA, Zimrin DA. Simultaneous “hybrid” percutaneous coronary intervention and minimally invasive surgical bypass grafting: Feasibility, safety, and clinical outcomes. Am Heart J 2008; 155: 661–667
   PubMed Web of Science ®Google Scholar
• Kon ZN, Brown EN, Tran R, Joshi A, Reicher B, Grant MC, Kallam S, Burris N, Connerney I, Zimrin D, et al. Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass. J Thorac Cardiovasc Surg 2008; 135: 367–375
   PubMed Web of Science ®Google Scholar
• Kiaii B, McClure RS, Stewart P, Rayman R, Swinamer SA, Suematsu Y, Fox S, Higgins J, Albion C, Kostuk WJ, et al. Simultaneous integrated coronary artery revascularization with long-term angiographic follow-up. J Thorac Cardiovasc Surg 2008; 136: 702–708
   PubMed Web of Science ®Google Scholar
• Hu SS. One-stop hybrid approach for cardiovascular disease: From conception to practice. Ann Thorac Cardiovasc Surg 2008; 14: 345–346
   PubMed Web of Science ®Google Scholar
• Bonatti J, Schachner T, Bonaros N, Jonetzko P, Ohlinger A, Ruetzler E, Kolbitsch C, Feuchtner G, Laufer G, Pachinger O, et al. Simultaneous hybrid coronary revascularization using totally endoscopic left internal mammary artery bypass grafting and placement of rapamycin eluting stents in the same interventional session. The COMBINATION pilot study. Cardiology 2008; 110: 92–95
   Google Scholar
• Kiaii B, McClure RS, Kostuk WJ, Rayman R, Swinamer S, Dobkowski WB, Novick RJ. Concurrent robotic hybrid revascularization using an enhanced operative suite. Chest 2005; 128: 4046–4048
   PubMedGoogle Scholar
• Byrne JG, Leacche M, Vaughan DE, Zhao DX. Hybrid cardiovascular procedures. JACC Cardiovasc Interv 2008; 1: 459–468
   PubMed Web of Science ®Google Scholar
• Poston RS, Tran R, Collins M, Reynolds M, Connerney I, Reicher B, Zimrin D, Griffith BP, Bartlett ST. Comparison of economic and patient outcomes with minimally invasive versus traditional off-pump coronary artery bypass grafting techniques. Ann Surg 2008; 248: 638–646
   PubMed Web of Science ®Google Scholar
• Byrne JG, Leacche M, Unic D, Rawn JD, Simon DI, Rogers CD, Cohn LH. Staged initial percutaneous coronary intervention followed by valve surgery ("hybrid approach") for patients with complex coronary and valve disease. J Am Coll Cardiol 2005; 45: 14–18
   PubMedGoogle Scholar
• Michelson AD. Platelet function testing in cardiovascular diseases. Circulation 2004; 110: e489–493
   PubMed Web of Science ®Google Scholar
• Yang YJ, Xu B, Chen JL, Kang S, Qiao SB, Qin XW, Yao M, Chen J, Wu YJ, Liu HB, et al. Comparison of immediate and followup results between transradial and transfemoral approach for percutaneous coronary intervention in true bifurcational lesions. Chin Med J (Engl) 2007; 120: 539–544
   PubMedGoogle Scholar
• Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, Costa MA. Variability in individual responsiveness to clopidogrel: Clinical implications, management, and future perspectives. J Am Coll Cardiol 2007; 49: 1505–1516
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Watson T, Lip GY. The role of aspirin in cardiovascular prevention: Implications of aspirin resistance. J Am Coll Cardiol 2008; 51: 1829–1843
   PubMed Web of Science ®Google Scholar
• Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126–2130
   PubMed Web of Science ®Google Scholar
• Shim JH, Jo WM, Chung WJ, Chung JH. Unexpected stent thrombus after minimally invasive direct coronary artery bypass in hybrid re-vascularisation. Eur J Cardiothorac Surg 2009; 419–421
   PubMedGoogle Scholar
• Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol 2007; 49: 2145–2150
   PubMed Web of Science ®Google Scholar
• Bednar F, Osmancik P, Vanek T, Mocikova H, Jares M, Straka Z, Widimsky P. Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: Results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and REactivity of Thrombocytes (CABARET). J Thorac Cardiovasc Surg 2008; 136: 1054–1060
   PubMed Web of Science ®Google Scholar
• Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, Bassi AK, Tantry US. Platelet reactivity in patients and recurrent events post-stenting: Results of the PREPARE POST-STENTING Study. J Am Coll Cardiol 2005; 46: 1820–1826
   PubMed Web of Science ®Google Scholar
• Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003; 107: 2908–2913
   PubMed Web of Science ®Google Scholar
• Zhao DX, Leacche M, Balaguer JM, Boudoulas KD, Damp JA, Greelish JP, Byrne JG, Ahmad RM, Ball SK, Cleator JH, et al. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. J Am Coll Cardiol 2009; 53: 232–241
   PubMedGoogle Scholar
• Maltais S, Perrault LP, Do QB. Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: Impact of discontinuation prior to surgery. Eur J Cardiothorac Surg 2008; 34: 127–131
   PubMed Web of Science ®Google Scholar
• Levine JC, Feseha H, KL M. Safety and efficacy of platelet inhibition during hybrid coronary revascularization. CHEST 2007; 132: 467S–468S
   Google Scholar
• L'Allier PL, Ducrocq G, Pranno N, Noble S, Ibrahim R, Gregoire JC, Azzari F, Nozza A, Berry C, Doucet S, et al. Clopidogrel 600-mg double loading dose achieves stronger platelet inhibition than conventional regimens: Results from the PREPAIR randomized study. J Am Coll Cardiol 2008; 51: 1066–1072
   PubMedGoogle Scholar
• Gladding P, Webster M, Zeng I, Farrell H, Stewart J, Ruygrok P, Ormiston J, El-Jack S, Armstrong G, Kay P, et al. The antiplatelet effect of higher loading and maintenance dose regimens of clopidogrel: The PRINC (Plavix Response in Coronary Intervention) trial. JACC Cardiovasc Interv 2008; 1: 612–619
   PubMed Web of Science ®Google Scholar
• Palmer GJ, Sankaran IS, Sparkman GM, Koster A, Dyke CM, Ebra G. Routine use of the direct thrombin inhibitor bivalirudin for off-pump coronary artery bypass grafting is safe and effective. Heart Surg Forum 2008; 11: E24–29
   PubMedGoogle Scholar
• Murphy GS, Marymont JH. Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2007; 21: 113–126
   PubMedGoogle Scholar
• Harrison P, Frelinger AL, 3rd, Furman MI, Michelson AD. Measuring antiplatelet drug effects in the laboratory. Thromb Res 2007; 120: 323–336
   PubMed Web of Science ®Google Scholar